These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17915203)

  • 1. Association of low repair efficiency with high hormone receptors expression and SOD activity in breast cancer patients.
    Agnoletto MH; Guecheva TN; Dondé F; de Oliveira AF; Franke F; Cassini C; Salvador M; Henriques JA; Saffi J
    Clin Biochem; 2007 Nov; 40(16-17):1252-8. PubMed ID: 17915203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative DNA damage and repair in a cell lineage model of human proliferative breast disease (PBD).
    Starcevic SL; Diotte NM; Zukowski KL; Cameron MJ; Novak RF
    Toxicol Sci; 2003 Sep; 75(1):74-81. PubMed ID: 12805649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects.
    Berstein LM; Tsyrlina EV; Poroshina TE; Levina VV; Vasilyev DA; Kovalenko IG; Semiglazov VF
    Exp Oncol; 2006 Mar; 28(1):64-9. PubMed ID: 16614711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients.
    Synowiec E; Stefanska J; Morawiec Z; Blasiak J; Wozniak K
    Mutat Res; 2008 Dec; 648(1-2):65-72. PubMed ID: 18977234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
    Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
    Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer.
    Blasiak J; Arabski M; Krupa R; Wozniak K; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Zadrozny M
    Mutat Res; 2004 Oct; 554(1-2):139-48. PubMed ID: 15450412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse mammary tumor-like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer.
    Faedo M; Ford CE; Mehta R; Blazek K; Rawlinson WD
    Clin Cancer Res; 2004 Jul; 10(13):4417-9. PubMed ID: 15240531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DNA-damaging potential of tamoxifen in breast cancer and normal cells.
    Wozniak K; Kolacinska A; Blasinska-Morawiec M; Morawiec-Bajda A; Morawiec Z; Zadrozny M; Blasiak J
    Arch Toxicol; 2007 Jul; 81(7):519-27. PubMed ID: 17593413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between telomerase activity and hormone receptor status and p53 expression in breast cancer.
    Mokbel K; Ghilchik M; Williams G; Akbar N; Parris C; Newbold R
    Int J Surg Investig; 2000; 1(6):509-16. PubMed ID: 11729859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interindividual differences in initial DNA repair capacity when evaluating H2O2-induced DNA damage in extended-term cultures of human lymphocytes using the comet assay.
    Andersson M; Stenqvist P; Hellman B
    Cell Biol Toxicol; 2007 Nov; 23(6):401-11. PubMed ID: 17429744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.
    Brouckaert O; Pintens S; Van Belle V; Van Huffel S; Camerlynck E; Amant F; Leunen K; Smeets A; Berteloot P; Van Limbergen E; Decock J; Hendrickx W; Weltens C; Van den Bogaert W; Vanden Bempt I; Drijkoningen M; Paridaens R; Wildiers H; Vergote I; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2009 May; 115(2):349-58. PubMed ID: 18629635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid peroxidation and antioxidant status in patients with breast cancer.
    Rajneesh CP; Manimaran A; Sasikala KR; Adaikappan P
    Singapore Med J; 2008 Aug; 49(8):640-3. PubMed ID: 18756349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation of CerbB-2 to Ki-67 and P53 expressions in hormone-independent breast cancer].
    Fang Q; Wang XF
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):380-2. PubMed ID: 21354936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of neoadjuvant chemotherapy on estrogen and progesterone receptors and P53 and CerbB-2 in breast cancer].
    Bao G; Yang DQ; Zhou B; Liu P; Wang S; Cheng L
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2843-5. PubMed ID: 18167290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation sensitivity of leukocytes from healthy individuals and breast cancer patients as measured by the alkaline and neutral comet assay.
    Shahidi M; Mozdarani H; Bryant PE
    Cancer Lett; 2007 Nov; 257(2):263-73. PubMed ID: 17881118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.
    Harigopal M; Heymann J; Ghosh S; Anagnostou V; Camp RL; Rimm DL
    Breast Cancer Res Treat; 2009 May; 115(1):77-85. PubMed ID: 18521745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.